Induction Healthcare Group PLC
("Induction", the "Company", or the "Group")
Results of 2022 Annual General Meeting ("AGM")
Induction Healthcare (AIM: INHC), a leading virtual care platform driving digital transformation of healthcare systems worldwide, held its AGM today at 50 Liverpool Street, London EC2M 7PY at 9.30am (GMT).
The poll results on each resolution proposed are available on the Company website.
All Ordinary Resolutions were passed. Special Resolutions 8, 9 and 10 did not pass. The Board notes the decision of shareholders in relation to these resolutions and will consult with shareholders to gain further feedback. Even so, the Board remains clear on the need to tightly manage costs and execute a plan ensuring the Group is correctly sized and on target to deliver a cash breakeven position during FY24.
ENQUIRIES
| Induction Christopher Samler, Executive Chair Paul Tambeau, Chief Operating Officer
| Via Walbrook PR Ltd: induction@walbrookpr.com
|
| |
|
| Singer Capital Markets (Nominated Adviser and Broker) | +44 (0)20 7496 3000 |
| Philip Davies |
|
| |
|
| Walbrook PR Ltd | +44 (0)20 7933 8780 or induction@walbrookpr.com |
| Alice Woodings / Paul McManus | Mob: +44 (0)7407 804 654 / +44 (0)7980 541 893 |
About Induction - www.inductionhealthcare.com
Induction (AIM: INHC) Induction delivers a suite of software solutions through a single integrated platform that transforms care delivery. Our system-wide applications help healthcare providers and administrators to deliver care at any stage remotely as well as face-to-face - giving the communities they serve greater flexibility, control and ease of access. Purpose-built for integration with leading Electronic Medical Record (EMR) platforms, our products offer immediate stand-alone value that becomes even greater when integrated with pre-existing systems.
Used at scale by national and regional healthcare systems, as well non-health government services, our applications are relied upon by hundreds of thousands of clinicians and millions of patients across almost every hospital in the British Isles.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
